Intangible Assets

3 Months Ended

Mar. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Intangible Assets

NOTE D — INTANGIBLE ASSETS

Intangible assets as of March 31, 2015 and December 31, 2014 consisted of the following (in thousands):

	Amortization Period	March 31, 2015
		COST		Accumulated Amortization		Net
Customer Relationships	156 months	$	1,930	$	108	$	1,822
Support Vector Machine (SVM) technology	108 months		500		181		319
Laboratory developed test (LDT) technology	164 months		1,482		324		1,158
Flow Cytometry and Cytogenetics technology	202 months		1,000		180		820
Total		$	4,912	$	793	$	4,119

	Amortization Period	December 31, 2014
		COST		Accumulated Amortization		Net
Customer Relationships	156 months	$	1,930	$	71	$	1,859
Support Vector Machine (SVM) technology	108 months		500		167		333
Laboratory developed test (LDT) technology	164 months		1,482		297		1,185
Flow Cytometry and Cytogenetics technology	202 months		1,000		165		835
Total		$	4,912	$	700	$	4,212

We recorded approximately $93,000 and $56,000 in straight-line amortization expense of intangibles in the three months ended March 31, 2015 and 2014, respectively. The Company recorded amortization expense from customer relationships as a general and administrative expense. We will continue to record the amortization of the Support Vector Machine (SVM) technology, the Laboratory developed tests (LDT) technology and the Flow Cytometry and Cytogenetics technology intangibles as a research and development expense until the time that we have products, services or cost savings directly attributable to these intangible assets that would require that it be recorded in cost of goods sold.

The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March 31, 2015 is as follows (in thousands):

Year Ending December 31,
Remainder of 2015	$	278
2016		371
2017		371
2018		371
2019		371
2020		371
Thereafter		1,986
Total	$	4,119